A Natural-Product Switch for a Dynamic Protein Interface

被引:26
作者
Scheepstra, Marcel [1 ]
Nieto, Lidia [1 ]
Hirsch, Anna K. H. [2 ]
Fuchs, Sascha [1 ]
Leysen, Seppe [1 ]
Chan Vinh Lam [1 ]
Panhuis, Leslie In Het [1 ]
van Boeckel, Constant A. A. [1 ]
Wienk, Hans [3 ]
Boelens, Rolf [3 ]
Ottmann, Christian [1 ]
Milroy, Lech-Gustav [1 ]
Brunsveld, Luc [1 ]
机构
[1] Tech Univ Eindhoven, Dept Biomed Engn, Lab Chem Biol & Inst Complex Mol Syst ICMS, NL-5612 AZ Eindhoven, Netherlands
[2] Univ Groningen, Stratingh Inst Chem, NL-9747 AG Groningen, Netherlands
[3] Univ Utrecht, NMR Spect, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands
关键词
drug discovery; natural products; nuclear receptors; protein-protein interactions; retinoid X receptor; SMALL-MOLECULE INHIBITORS; RETINOID-X-RECEPTOR; THYROID-HORMONE RECEPTOR; COACTIVATOR BINDING; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; DRUG DISCOVERY; BIOLOGICAL EVALUATION; NUCLEAR; MODULATORS;
D O I
10.1002/anie.201403773
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Small ligands are a powerful way to control the function of protein complexes via dynamic binding interfaces. The classic example is found in gene transcription where small ligands regulate nuclear receptor binding to coactivator proteins via the dynamic activation function 2 (AF2) interface. Current ligands target the ligand-binding pocket side of the AF2. Few ligands are known, which selectively target the coactivator side of the AF2, or which can be selectively switched from one side of the interface to the other. We use NMR spectroscopy and modeling to identify a natural product, which targets the retinoid X receptor (RXR) at both sides of the AF2. We then use chemical synthesis, cellular screening and Xray co-crystallography to split this dual activity, leading to a potent and molecularly efficient RXR agonist, and a first-of-kind inhibitor selective for the RXR/coactivator interaction. Our findings justify future exploration of natural products at dynamic protein interfaces.
引用
收藏
页码:6443 / 6448
页数:6
相关论文
共 48 条
[1]   Ligand efficiency indices for effective drug discovery [J].
Abad-Zapatero, Cele .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (04) :469-488
[2]   RAR and RXR modulation in cancer and metabolic disease [J].
Altucci, Lucia ;
Leibowitz, Mark D. ;
Ogilvie, Kathleen M. ;
de Lera, Angel R. ;
Gronemeyer, Hinrich .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :793-810
[3]  
[Anonymous], THE PYMOL MOLECULAR
[4]   Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators [J].
Arnold, LA ;
Estébanez-Perpiñá, E ;
Togashi, M ;
Jouravel, N ;
Shelat, A ;
McReynolds, AC ;
Mar, E ;
Nguyen, P ;
Baxter, JD ;
Fletterick, RJ ;
Webb, P ;
Guy, RK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :43048-43055
[5]   Inhibitors of the interaction of a thyroid hormone receptor and coactivators:: Preliminary structure-activity relationships [J].
Arnold, Leggy A. ;
Kosinski, Aaron ;
Estebanez-Perpina, Eva ;
Fletterick, Robert J. ;
Guy, R. Kiplin .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) :5269-5280
[6]  
Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]
[7]   The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways [J].
Banerjee, Pallavi ;
Basu, Aninda ;
Arbiser, Jack L. ;
Pal, Soumitro .
CANCER LETTERS, 2013, 338 (02) :292-299
[8]   Synthetic Retinoids: Structure-Activity Relationships [J].
Barnard, Jonathan H. ;
Collings, Jonathan C. ;
Whiting, Andrew ;
Przyborski, Stefan A. ;
Marder, Todd B. .
CHEMISTRY-A EUROPEAN JOURNAL, 2009, 15 (43) :11430-11442
[9]  
Becerril J., 2007, ANGEW CHEM, V119, P4555
[10]   Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides [J].
Becerril, Jorge ;
Hamilton, Andrew D. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (24) :4471-4473